Quantum dots (QDs) are fluorescent semiconductor nanocrystals that have the potential for major advancements in the field of nanomedicine through their unique photophysical properties. They can potentially be used as fluorescent probes for various biomedical imaging applications, including cancer localization, detection of micrometastasis, image guided surgery, and targeted drug delivery. Their main limitation is toxicity, which requires a biologically compatible surface coating to shield the toxic core from the surrounding environment. However, this leads to an increase in QD size that may lead to problems of excretion and systemic sequestration. We describe a one pot synthesis, characterization, and in vitro cytotoxicity of a novel polyhedral oligomeric silsesquioxane (POSS)-coated CdTe-cored QD using mercaptosuccinic acid (MSA) and D-cysteine as stabilizing agents. Characterization was performed using transmission electron microscopy Fourier transform infrared spectroscopy, and photoluminescence studies. POSS-coated QDs demonstrated high colloidal stability and enhanced photostability on high degrees of ultraviolet (UV) excitation compared to QDs coated with MSA and D-cysteine alone (P value < 0.05). In vitro toxicity studies showed that both POSS and MSA-QDs were significantly less toxic than ionized salts of Cd(+2) and Te(-2). Confocal microscopy confirmed high brightness of POSS-QDs in cells at both 1 and 24 hours, indicating that these QDs are rapidly taken up by cells and remain photostable in a biological environment. We therefore conclude that a POSS coating confers biological compatibility, photostability, and colloidal stability while retaining the small size and unique photophysical properties of the QDs. The amphiphilic nature of the coating allows solubility in aqueous solutions and rapid transfer across cell membranes, enabling the use of lower concentrations of the QDs for an overall reduced toxicity particularly for prolonged live cell and in vivo imaging applications.
Quantum dots (QDs) are fluorescent semiconductor nanocrystals that have the potential for major advancements in the field of nanomedicine through their unique photophysical properties. They can potentially be used as fluorescent probes for various biomedical imaging applications, including cancer localization, detection of micrometastasis, image guided surgery, and targeted drug delivery. Their main limitation is toxicity, which requires a biologically compatible surface coating to shield the toxic core from the surrounding environment. However, this leads to an increase in QD size that may lead to problems of excretion and systemic sequestration. We describe a one pot synthesis, characterization, and in vitro cytotoxicity of a novel polyhedral oligomeric silsesquioxane (POSS)-coated CdTe-cored QD using mercaptosuccinic acid (MSA) and D-cysteine as stabilizing agents. Characterization was performed using transmission electron microscopy Fourier transform infrared spectroscopy, and photoluminescence studies. POSS-coated QDs demonstrated high colloidal stability and enhanced photostability on high degrees of ultraviolet (UV) excitation compared to QDs coated with MSA and D-cysteine alone (P value < 0.05). In vitro toxicity studies showed that both POSS and MSA-QDs were significantly less toxic than ionized salts of Cd(+2) and Te(-2). Confocal microscopy confirmed high brightness of POSS-QDs in cells at both 1 and 24 hours, indicating that these QDs are rapidly taken up by cells and remain photostable in a biological environment. We therefore conclude that a POSS coating confers biological compatibility, photostability, and colloidal stability while retaining the small size and unique photophysical properties of the QDs. The amphiphilic nature of the coating allows solubility in aqueous solutions and rapid transfer across cell membranes, enabling the use of lower concentrations of the QDs for an overall reduced toxicity particularly for prolonged live cell and in vivo imaging applications.
Nanomaterials have dimensional analogies similar to physiological molecules such as
proteins and nucleic acids1 and therefore
have been exploited in various biomedical applications, such as tissue engineering,
biosensing, medical diagnostics, and therapeutics. At nanoscale sizes, the properties of
bulk matter change considerably, giving nanomaterials superior mechanical, thermal,
electrical, magnetic, and optical properties that can be exploited extensively in the field
of biomedicine. Of the many nanomaterials, particles < 100 nm in diameter are defined as
nanoparticles and are of considerable interest to the biomedical scientist. Nanoparticles
may be conjugated to biological molecules and incorporated into drug carrier systems,
mechanical scaffolds for tissue engineering, and use as contrast agents for in vivo real
time imaging applications.2–6Quantum dots (QDs) are fluorescent nanoparticles of semiconductor material with unique
photophysical properties that give them significant advantages over organic dyes and
proteins commonly used in biomedical imaging.7 QDs can be size tuned to emit at variable wavelengths ranging all the way from
the ultraviolet UV to the near infrared (NIR). Having a broad absorption and narrow emission
spectrum, they can be used for multiplexed imaging as differently colored QDs can be excited
by the same wavelength of light1,8,9 provided this wavelength is less than their absorption onset. The QD surface
carries free reactive groups that allow biofuctionalization for their targeted delivery.
These properties, along with their higher sensitivity, quantum yields, photostability,
chemical stability, molar extinction coefficients, and slow decay rates make them ideal
probes for real time, long term, and multimodal biomedical imaging.The most commonly synthesized QDs are based on cadmium salts (eg, cadmium telluride and
cadmium selenide), which are coated by a material of a higher band gap, eg, zinc sulphide or
cadmium sulphide.10,11 Furthermore, most QDs are organically synthesized and are
insoluble in aqueous media, which makes them inapplicable to biological scenarios. Although
QDs can now be aqueously synthesized, their toxicity limits their biomedical application. QD
toxicity is multifactorial and is determined by their physiochemical properties, including
composition of the core, size, surface charge, concentration, surface chemistry,
bioactivity, oxidative, photolytic and mechanical stability, as well as their environmental
interactions.12 The main mechanism of
toxicity is the release of free divalent cadmium ions into the surrounding environment
through the effects of core oxidation due to the surface coating, which is inadequate or
unstable to shield the core from the surrounding oxidative environment. However, the surface
coating increases QD size and leads to sequestration in organs of the reticuloendothelial
system, including the liver and spleen as they are too large for renal excretion.13 The liver is the main target of cadmiumtoxicity, and since larger QDs accumulate in the liver, this effect is likely to be
accentuated.Over the last decade, QD toxicity and surface coatings to render them biologically
compatible have been intensively researched. Various materials have been used to protect the
QD core from the effects of an oxidative biological environment,9,14,15 but there are problems of toxicity of the
surface coating itself, which is prone to instability and biodegradation. Moreover, surface
coating may lead to an overall increase in QD size, which relies on the method of coating,
including ligand exchange or ligand capping. Ligand exchange leads to smaller particles that
can be applied to biosensing applications but entail a certain amount of loss of QD
fluorescence. Alternatively, ligand capping coats the QDs with its surrounding surface
groups, which leads to a larger hydrodynamic diameter but also the retention of its unique
photophysical properties.15 QDs coated by
this technique can be applied to various diagnostic applications determined by their
eventual size.We demonstrate the application of polyhedral oligomeric silsesquioxane (POSS) as a novel
surface coating for QDs. POSS is a cyclical silsesquioxane with a stoichiometric formula
(SiO1.5)8 and is the smallest
of the silica nanoparticles with a size of 1.5 nm16 (Figure 1). We have previously
integrated POSS as a nanocomposite into a synthetic polymer polycarbonate urea urethane and
used it for biomedical tissue engineering applications, such as vascular grafts, heart
valves, nerve grafts15,17–26 and more recently as a nasolacrimal duct and a tracheal
graft, which have successfully been implanted into patients. POSS imparts properties of
antithrombogenicity, biocompatibility, non-immunogenicity, and increased surface area to
promote endothelialization. We have also used the emulsion form of this novel nanocompositepolymer to coat QDs.27 POSS-PCU
emulsion-coated QDs were biocompatible and more photostable than mercaptoundecanoic acid
(MUA)-coated QDs but have a hydrodynamic diameter of ~33 nm. In this paper, we describe the
application of a novel POSS coating to mercaptosuccinic acid (MSA) and D-Cysteine stabilized
CdTe core QDs synthesized by modification of a simple one pot aqueous synthesis as
previously described.6,28 MSA achieves dispersibility and pH
stability while D-cysteine acts as an anti-oxidant and adds both NH2 and
–COOH groups for biofunctionalization. POSS imparts properties of colloidal
stability, photostability, and amphiphillicity, allowing high intracellular uptake and lower
concentrations of the QDs to be used for overall enhanced biocompatibility.
Figure 1
Structure of QDs and M-POSS.
Notes: (A) MSA-QDs; (B) POSS-QDs;
(C) M-POSS. MSA-QDs have ample surface COOH groups to allow solubility
and stability. POSS-QDs have both hydrophobic and hydrophilic surface groups, giving
them amphiphilic properties. Structure of M-POSS (C) shows a caged
structure with predominant Si-O-Si and surface Si-C bonds. R groups promote solubility
in organic solvents and thiol (-SH) group binds to QD core metal surface.
Sodium borohydride (NaBH4, 98%), sodium tellurite
(Na2TeO3 99.8%), cadmium chloride (CdCl2), MSA,
D-cysteine (99.5%) and mercaptopropylisobutyl-POSS (M-POSS) were purchased from
Sigma-Aldrich Chemicals (St Louis, MO). All chemicals were used as obtained without
further purification. Dulbecco’s modified eagle’s medium (DMEM +
4.5 g/l glucose), fetal bovine serum (FBS) and penicillin/ streptomycin, Trypsin/EDTA, and
phosphate-buffered saline (PBS) were purchased from GIBCO/Invitrogen (UK).
CellTitre-Blue® viability assay was purchased from Promega (Madison,
WI, USA).
Synthesis and coating of CdTe QDs
Briefly, borate-citrate acid-buffer solution was prepared using 15 mM sodium borate
(Na2B4O7) and 15 mM citric acid and then pH adjusted
with 1 M HCL or 1 M NaOH. The precursor solution was prepared using cadmium chloride
(CdCl2, 1 mM) and sodium tellurite (Na2TeO3, 0.25 mM),
to which 0.1 mM of thiolated D-cysteine and 1 mM MSA was added. The materials were mixed
in a single-necked flask immersed in ice and containing 50 mL of the buffer solution.
After 5 minutes of vigorous stirring, 20 mg of sodium borohydride (NaBH4)
powder was added, and the reaction was allowed to proceed for another 5 minutes before
attaching the flask to a condenser and refluxing at 100°C under open-air
conditions for approximately 6 hours. The emission color of the QDs could be controlled by
altering reflux time. The QDs were purified from the suspension by centrifugation with an
equal volume of ethanol for 20 mins. The QDs obtained were MSA/D-cysteine-coated and
referred to as MSA-QDs.
Synthesis of POSS-coated CdTe QDs
Mercaptopropylisobutyl-POSS was first dissolved in tetrahydrofuran (THF) and then added
to the precursor solution at a concentration of 0.1 mM along with 0.1 mM of D-cysteine and
1 mM solution of MSA. The solution was refluxed for the same period of time as the
MSA-QDs. The QDs were purified with centrifugation with an equal volume of THF. The
POSS/MSA/D-cysteine-coated QDs obtained were referred to as POSS-QDs. The final QD
concentrations were calculated from the dry weight, and the QDs were suspended in PBS.
Characterization studies
Photoluminescence spectra were obtained using a fluorescence emission spectroscope USB
2000+ (Ocean Optics, Dunedin, FL) using a quartz cuvette with a 1 cm path length
and an aqueous solvent (deionized water or PBS) as a reference. QD samples were
illuminated with a LED beam at 375 nm. Photostability of POSS and MSA QDs was assessed by
exposing equal concentrations of QDs to continuous UV excitation at 375 nm for 2 hours,
and emission intensity was recorded at sequential intervals. The emission intensities were
normalized before comparison. The shape and size of the different QDs cores were assessed
using transmission electron microscopy. A drop of QD samples was mounted on to a Piloform
(TAAB)-coated G300HS copper electron microscopy grid (Gilder) and allowed to air dry. The
grids were examined with a CM120 (Philips) transmission electron microscope at 3.0
× 105 magnification. Fourier transform infrared spectra were obtained
on a Jasco FT/IR 4200 spectrometer equipped with a diamond attenuated total reflectance
accessory (Diamond MIRacle ATR, PikeTechnologies, US). Spectra were produced from an
average of 20 scans at 4 cm−1 resolution over a range of 600
cm−1 to 4000 cm−1 wavenumbers. For POSS and
MSA-QDs, aqueous samples were run against a background generated from PBS solution. Dry
MSA powder and M-POSS were run again against a background of air.
Cell culture
Hep G2 cells were supplied at passage number 50 from the Liver Group at the Centre for
Hepatology, Department of Medicine, Royal Free Hospital and Medical School, University
College London. Once received, the media was changed to Dulbecco’s modified
eagle’s medium (DMEM + 4.5 g/l glucose) and supplemented with fetal bovine
serum (FBS, 10%) and penicillin/streptomycin (1%), which was then replaced
a few times during a period of 1 week to 10 days. Part of the supply was cryopreserved for
future use, and the rest was maintained ready for use as needed. The cells were seeded
into flasks and cultured at 37°C and 5% CO2 under aseptic
conditions. Cells were grown to 90% confluence before being used for routine
passaging and in vitro toxicity experiments.
Cell viability studies
Serial dilutions (0, 1.5, 5, 10, and 15 μg/mL) of CdCl2,
Na2TeO3, and different QDs were prepared using PBS and media,
whereby the volume of DMEM was kept constant. HepG2 cells were seeded into 96-well plates
at a density of 2 × 104 cells per well, and allowed to settle for 24
hours at 37°C in an incubator with 5% CO2. After this period,
the media was removed. The cells were thoroughly washed with PBS and then exposed to
serial dilutions of the CdCl2, Na2TeO3 and three
different types of QDs, and then incubated at 37°C in 5% CO2
for 1 and 24 hours. After this period, the cells were thoroughly washed with PBS, and the
QD dilutions were replaced with DMEM. Twenty μl of the
CellTitre-Blue® dye was then added to each well and incubated for
further 4 hours at 37°C in 5% CO2. All tests were conducted in
triplicate. Cells not exposed to any QD dilution (0 μg/100 μl) served as a
negative control and those exposed to ionized Cd+2 and
Te−2 served as positive controls for toxicity.
Confocal microscopy to assess cell morphology and QD stability
For confocal microscopy, cells were plated in flat-bottomed glass 96-well plates and
exposed to QD dilutions as above. They were washed with PBS, fixed with gluteraldehyde,
and examined using an EC-1 confocal microscope from Nikon. Each respective image was
optimized by averaging 10 scans per image.
Statistical analysis
Statistical analysis was performed using Prism software and one-way ANOVA with the
Dunnett and Bonferroni multiple comparison test and paired t test.
Results
Synthesis
The CdTe core QDs were synthesized by a previously described one pot aqueous method based
on the reaction between CdCl2 and Na2TeO3 in a
borate-citrate buffer.6,27 Bao et al were the first to describe a
one pot aqueous synthesis of L-cysteine capped CdTe nanocrystals using sodium tellurite as
a Tellurium source.28 The same group
adapted this technique to demonstrate the synthesis of highly luminescent MSA capped CdTe
QDs.6 We made minor modifications to
this protocol with respect to the coating materials to yield two different types of QDs
coated with MSA and D-cysteine (referred to as MSA-QDs) and mercaptopropylisobutyl- POSS
(M-POSS), MSA and D-cysteine (referred to as POSS-QDs) (Figure 1).The synthesis of MSA-QDs involved preparing a precursor solution by mixing cadmium
chloride, sodium tellurite, MSA, and D-cysteine in a borate citrate buffer. When sodium
borohydride was added, the color of the growth solution instantly turned a light green. On
heating the mixture at 100°C for 1 hour, the color darkened to a deep green and
eventually to brown at the end of 6 hours. By altering the reflux time, QD emission of the
desired wavelength could be achieved with bluish fluorescence (450 nm) at the end of 1 h,
yellow (550 nm) at 4 h and red (635 nm) at 6 h. Reflux times of greater than 6 h led to
the solution becoming unstable with evidence of aggregation and loss of fluorescence. It
is likely that prolonged heating may lead to breakdown of the thiol groups to form a CdS
shell initially followed by oxidation of the cysteine residues to cystine with formation
of a disulphide bond. MSA QDs were purified after centrifugation with equal amounts of
isopropanol and resuspended readily in PBS. However, the MSA-QDs lacked colloidal
stability as they fell out of solution under prolonged standing in refrigeration within a
few days.For the synthesis of POSS-QDs, Mercaptopropylisobutyl- POSS (M-POSS) was dissolved in
tetrahydrofuran to make a 0.1 mM solution. This was added to the precursor solution,
including cadmium chloride, sodium tellurite, MSA, and D-cysteine in 50 mL of buffer
solution in a single-necked flask immersed in ice and subjected to vigorous stirring in a
homogenizer. The initial temperature of the flask was kept low to prevent initiation of
the reaction prior to addition of all the materials. As an organic solvent was added to
the aqueous solution, vigorous stirring was required to form a homogenous mixture. After
addition of the reducing agent, sodium borohydride, the reaction proceeded as previously.
At the end of 6 hours, a brown colored solution was obtained with some precipitates of
free POSS present in the base of the flask. POSS-QDs emitting at 630 nm were purified with
centrifugation with an equal amount of tetrahydrofuran to remove any unreacted M-POSS.
They readily suspended in PBS and remained colloidally stable on prolonged standing at
4°C in refrigeration for months. Successful coating of the QDs was later confirmed
by Fourier transform infrared spectroscopy (FTIR) analysis.The core diameter, shape, and degree of dispersion of the QDs were assessed using
transmission electron microscopy ( Figure
2). Both QDs were spherical in shape and had a mean core diameter of 3.3 nm.
MSA-QDs appeared to be marginally better dispersed than POSS-QDs. Photoluminescence
studies showed that MSA-QDs emitted at 635 nm, whereas POSS- QDs showed a marginal blue
shift in emission at 630 nm (Figure
3).
Figure 2
Transmission electron microscopy.
Notes: (A) POSS-QDs; (B) MSA-QDs. The core sizes
of CdTe in (A) and (B) are 3.3 nm. Both QDs (A
and B) were well dispersed, although some darker areas in A
may reflect free POSS. Scale bars represent 20 nm. Magnification × 300,000.
Fluorescence emission spectra of POSS and MSA-QDs.
Notes: POSS-QDs emit at 630 nm and MSA-QDs at 635 nm. There is no
significant difference in the peak emission wavelength of both QDs, although POSS-QDs
have a slightly broader FWHM compared to MSA-QDs.
The FTIR spectra of dry MSA powder, MSA-QDs, POSS-QDs, and M POSS are shown in Figure 4. Both MSA and POSS-QDs show prominent
peaks at 1565 cm−1 and 1402 cm−1, which correspond
to strong asymmetric and symmetric stretching vibrations of amino acid cysteine,
respectively. The peak as 1402 cm−1 (MSA-QDs) and 1403
cm−1 (POSS-QDs) is strongest at it also receives some contribution
from weak deformation of O-H groups from the MSA (1418 cm−1). MSA-QDs
show a slight shift in the peak at 1646 cm−1 from 1689
cm−1 in the MSA powder caused by carbonyl stretching vibrations,
indicating that MSA has bonded to the QD surface. POSS-QDs show a new peak at 1043
cm−1 from variable strong stretching vibrations of the Si-O-Si bonds
in the POSS nanocages. The FTIR spectrum of M-POSS indicates a strong peak at 1080
cm−1 from the Si-O-Si bonding of the POSS nanocages. The shift in
this peak from 1080 cm−1 in M-POSS to 1043 cm−1 in
POSS-QDs indicates that the POSS has bonded to the QD surface. Both POSS and MSA QDs have
cysteine residues and MSA groups, which relate to the similarity of their FTIR spectra,
except for the POSS peak that occurs at 1043 cm−1 and a slightly more
prominent broad peak at 1154 cm−1 in POSS-QDs caused by skeletal
vibrations of alkyl C-C groups from the isobutyl alkyl groups on the POSS nanocages.
Figure 4
FTIR spectra of dry MSA powder, MSA-QDs, POSS-QDs and M-POSS.
Notes: (A) POSS and MSA-QDs show common peaks at 1402
cm−1 and 1565 cm−1 from strong symmetric and
asymmetric vibrations of the amino acid cysteine. However, POSS-QDs show a new peak at
1043 cm−1 that corresponds to stretching vibrations from Si-O-Si
bonds in POSS; (B) M-POSS demonstrates a prominent peak at 1087
cm−1 from Si-O-Si bonds that shifts to a 1043
cm−1 on the POSS-QDs indicating that POSS has bonded to the QD
surface.
POSS-QDs were more resistant to photo-oxidation on exposure to high degrees of UV
illumination compared to MSA-QDs (P-value < 0.05) (Figure 5). Although both types of QDs
photo-degraded over the period of exposure, the rate of decline of the emission intensity
of POSS-QDs was considerably less than MSA-QDs. POSS-QDs remained photostable for the
initial 20 minutes of UV exposure and lost 25% of their emission intensity over a
period of 1 hour. In comparison, MSA-QDs lost >25% of their emission intensity
in the first 20 minutes and >50% after the first hour of exposure.
Figure 5
Photostabilty of POSS and MSA-QDs.
Notes: On exposure to UV illumination for 2 hours, POSS-QDs undergo
photo-oxidation at a much slower rate showing significantly enhanced photostability
compared to MSA-QDs. P value < 0.05.
In vitro toxicity of individual heavy metals of CdCl2 and
Na2TeO3 was carried out to establish the toxicity of free divalent
Cd+2 and Te−2 ions, which was compared with
toxicity of the two different types of QDs. Both tellurium and cadmium individually
demonstrated significant time and concentration dependent cytotoxicity (Figure 6). Cadmiumtoxicity was more
pronounced even at low concentration of 1.25 μg/mL at 1 hour
(P-value < 0.01). At 24 h exposure, all concentrations of cadmium
showed less than 10% cell viability versus tellurium, which showed a similar
effect at 5 μg/mL.
Figure 6
In vitro toxicity of ionized Cd+2 and Te−2 to Hep
G2 cells.
Notes: Both metals have profound toxicities, with cadmium being toxic at
all concentrations at 1 and 24 hours compared with tellurium, which is toxic at all
concentrations except 1.25 μg/mL at 1 hour.
**P < 0.01.
Hep G2 cells exposed to MSA and POSS-QDs showed no significant evidence of toxicity at
concentrations of 2.5 μg/mL at both 1 h and 24 h of exposure (Figure 7). At the end of 1 h, the first signs of toxicity
appeared at 5 μg/mL even though both POSS and MSA-QDs maintained greater than
85% cell viability at all concentrations up to 15 μg/mL. There was no
significant difference in toxicity between the two QDs at 1 h of exposure. At 24 h, POSS-
QDs showed significantly reduced cell viability at 5 μg/mL compared to MSA-QDs
(P-value < 0.01) even though they maintained a cell viability of
~90%. The slightly greater cell viability of both POSS and MSA QDs at 24 h
compared to 1 h, at 5 μg/mL indicates that both QDs do not affect the
multiplication potential of cells at this concentration. At higher concentrations of
≥10 μg/mL both POSS and MSA QDs were toxic at 24 h
(P-value < 0.01). Although there was no significant difference in cell
viability between the two QDs at higher concentrations, MSA-QDs showed marginally higher
cell viability (~70%) compared to POSS-QDs (~65%) at the highest
concentration of 15 μg/mL (Figure
7).
Figure 7
In vitro toxicity of POSS and MSA-QDs to Hep G2 cells.
Notes: Different concentrations of QDs were compared to the control group.
Both POSS and MSA-QDs are biocompatible at 2.5 μg/mL at 1 and 24 hours. POSS-QDs
show lower cell viability at 5 μg/mL at 24 hours compared to MSA-QDs, although
there is no significant difference in cell viability between the 2 QDs at higher
concentrations of 10 and 15 μg/mL. *P <
0.05; **P < 0.01.
Confocal images of HepG2 cells exposed to the highest QD concentration (15 μg/mL)
were taken to demonstrate changes in cell morphology and uptake of QDs after 1 and 24
hours of exposure (Figures 8 and 9, respectively). At 1 hour post incubation,
there was no visible difference in morphology between cells exposed to POSS and MSA-QDs.
However, at 24 hours post incubation, cells exposed to Cd+2 displayed
marked evidence of cell death with loss of cellular architecture and evidence of cellular
break down. POSS and MSA QDs exhibited distinctly higher cell numbers and intracellular
fluorescence. The fluorescence of POSS-QDs was more predominant at both 1 and 24
hours.
Figure 8
Confocal images of HepG2 cells incubated with QDs for 1 hour. (A)
Differential interference contrast (DIC) image of cells incubated with MSA-QDs;
(B) Fluorescent image of A; (C) DIC image of cells incubated
with POSS-QDs; (D) Fluorescence image of C; POSS-QDs
(D) appear more brightly fluorescent than MSA-QDs (B) at 1
hour.
Notes: The images are pseudo-colored. The scale bar is set to 50
μm.
Confocal images of HepG2 cells incubated with QDs for 24 hours.
Notes: (A) differential interference contrast (DIC) Image of
cells exposed to MSA-QDs; (B) Fluorescent image of A;
(C) DIC image of cells exposed to POSS-QDs (D) Fluorescence
image of C. Both POSS and MSA-QDs maintain high cellular numbers and
intracellular fluorescence indicating uptake of QDs. POSS-QDs (D) appear
brighter than MSA-QDs (C).
The synthesis of highly luminescent MSA and L-cysteine capped CdTe QDs has previously been
described.6,28 We modified the same technique to apply a POSS coating and
replaced the conventionally used L-cysteine with its enantiomer D-cysteine. L-cysteine is a
small amino acid present in the human body and susceptible to degradation by physiological
proteases. As D-cysteine is resistant to such degradation,29 we hypothesized that it would provide superior protection
to the QD core in a biological environment while retaining the advantages of the L-cysteine
molecule. D-cysteine has both NH2 and COOH groups, which solubilize the QDs and
provide free reactive groups for the attachment of biomolecules. We did not investigate the
effects of pH, molar ratios, and reaction temperature on QD synthesis. Our aim was to apply
a novel POSS coating to MSA and D-cysteine stabilized CdTe core QDs and establish its effect
on their eventual biocompatibility and QD photophysical properties.Both POSS and MSA-QDS were monodispersed with a core diameter of 3.3 nm on a transmission
electron microscopy (TEM) although MSA-QDs showed marginally better dispersibility than
POSS-QDs (Figure 2). TEM does not assess the
hydrodynamic diameter of QDs as the soft organic coating is not electron dense and therefore
invisible. The MSA-QDs are compact as both MSA and cysteine residues are fairly small.
Previous DLS studies to evaluate the hydrodynamic diameter of L-cysteine capped CdTe/ZnTe
QDs suggested that cysteine adds 0.3–0.5 nm to the original QD size,30 keeping the overall size of the QDs fairly
small. POSS is a small molecule with a diameter of only 1.5 nm including R groups. We
speculate that because it replaces some of the MSA groups on the QDs surface, it does not
significantly alter the overall hydrodynamic (HD) diameter compared to MSA QDs. The MSA
coating provides 2 carbonyl groups that enhance miscibility and dispersibility as evident on
TEM. However, after prolonged standing, the MSA-QDs appear to fall out of solution as
compared to the POSS-QDs that maintain dispersibility and colloidal stability for prolonged
periods of time.POSS-QDs have all three residues on their surface, including D-cysteine, MSA, and M-POSS.
The ratio of D-cysteine and POSS is very low compared to MSA (1:1:10, respectively), which
serves as the main stabilizing agent. The POSS cage is ~1.5 nm in diameter,16 and on its own is extremely hydrophobic. In
the presence of MSA and D-Cysteine, it imparts amphiphilic properties to the QD. POSS is a
robust molecule that has been incorporated into various polymers to protect the underlying
surface from the effects of oxygen plasma.16 It is likely that the POSS coating confers prolonged colloidal stability
through reducing QD aggregation and maximally shielding the core from the oxidative effects
of air and light.Photoluminescence studies showed that MSA-QDs emitted at 635 nm while POSS-QDs showed a
marginal blue shift in emission at 630 nm (Figure
3). A possible explanation of this effect may be the initial loss of few atoms from
the QD surface during the process of ligand exchange as M-POSS replaces some MSA groups on
the QD surface. This phenomenon is a well-established sequele of ligand exchange reaction,
which is one of the mechanisms of coating QDs for aqueous solubility.15 Most commercially available QDs have a core/shell structure
with a surface coating for solubility. Although both POSS and MSA-QDs emit at red
wavelengths, they are core QDs without a shell and with small molecule thiol surface
coating, which keeps the overall size of the QDs smaller than core/shell or core/shell/shell
structures. The small size is a beneficial feature, particularly for various biosensing
applications that track the movement of individual molecules within cells. Moreover, smaller
particles are less likely to be taken up and accumulate in the reticuloendothelial system
and more likely to be excreted by the kidneys.13 Studies have proven the direct association between long-term retention of large
cadmium-based QDs in the liver and its associated toxicity.31The photostability of both POSS and MSA-QDs was assessed using prolonged UV excitation
using a high powered lamp. POSS-QDs have significantly higher photostability after two hours
of UV exposure (Figure 5). Although the
degree of UV excitation used in this experiment was very high and unlikely to be replicated
in a biological environment, it gave an indication of the photochemical stability of the
different coatings in extreme oxidative environments. The relative protective effect of POSS
in retarding UV induced photooxidation may be related to the inherent structure of the POSS
molecule. The Si-O bonds in the POSS structure are most resistant to breakdown compared to
the Si-C bonds. In extreme exposures to oxidative environments, all the bonds may break down
except the Si-O bond, which may form SiO2 and protect the underlying QD from the
effects of UV. This phenomenon has been demonstrated when POSS has been integrated as a
nanocomposite in polymers for surface coatings32 and exposed to oxygen plasma. The SiO2 layer may prevent the loss of
excitons, leading to enhanced photostability of POSS-QDs.Previous studies have demonstrated that a QD concentration of only 10 μg/mL was
toxic to HepG2 cells.33–35 The cytotoxicity of cadmium based core QDs
lacking a ZnS shell has also been well established.36 Because our QDs lacked a ZnS coat, we used 15 μg/mL
as the highest concentration to evaluate cytotoxicity. It can be assumed that a surface
coating that nullifies or reduces QD core toxicity would yield much greater biocompatibility
with core/shell QDs. Core QDs may also be a more sensitive tool to assess QD toxicity
because the slightest instability or breakdown of the surface coating would lead to an
immediate oxidation of the core, manifesting as enhanced toxicity or photochemical
instability.The marginally lower cell viability on exposure to POSS- QDs compared to MSA QDs (Figure 7) can be explained by the possibility
that POSS-QDs are rapidly taken up by the cells as evidenced by the brighter
photoluminescence of cells on confocal microscopy at both 1 and 24 hr (Figures 8 and 9). The ideal method of confirming a high intracellular uptake would be a TEM that
would allow counting the number of particles within the cells or determining the
intracellular cadmium content through inductively coupled plasma mass spectroscopy of cell
lysates. Quantification of fluorescence may not be ideal in this situation as the POSS-QDs
are significantly more photostable than MSA-QDs, and the brighter fluorescence may just be
an indicator of photostability. However, we speculate that POSS-QDs have a surface coating
with both hydrophobic and hydrophilic moieties, giving them amphiphilic properties, which
may allow rapid intracellular uptake across the lipophilic cell membranes leading to
slightly higher toxicity compared to MSA-QDs at concentrations ≥ 5 μg/mL at
24 h. In a recent report, Su et al37
demonstrated that the cytotoxicity of QDs cannot be solely attributed to the release of free
Cd2+ ions but is actually determined by the number of QDs ingested by
the cell. Our results correlate with those of previous studies showing concentration and
time dependent toxicity of QDs.12,14,35At one hour post-incubation, both POSS and MSA QDs were taken up by the cells and localized
to the cytoplasm. The main mechanism of intracellular delivery of QDs is endocytic uptake,
which is likely to be the mechanism by which both QDs were taken up. However, this method is
very non-specific and leads to aggregation of QDs in vesicles and a non-uniform cytoplasmic
distribution. QD sequestration into vesicles may also be a barrier to various clinical
applications, eg, QD-bioconjugates as drug-delivery systems, since intracellular delivery
requires the QD-drug complex to be freely available for interactions. Trapped QDs, however,
cannot reach the intended target and thus render the system futile. Other methods of QD
uptake by cells include techniques such as microporation and microinjection of QDs38,39 into individual cells, which appears to be the only means of homogeneous
intracellular QD delivery to date. However, the major drawback of this technique is the
single cell approach, which makes it a laborious process and thus precludes large-scale
applications.A major finding of our study was that the degree of QD fluorescence in cells was
considerably higher for the POSS-QDs compared to the MSA-QDs, particularly at 1 h post
incubation. It is possible that the mechanism of QD uptake for POSS-QDs differs from MSA QDs
such that the former are rapidly taken up by pathways other than nonspecific endocytosis,
leading to increased QD concentration within the cells and higher intracellular
fluorescence. It has been previously demonstrated that QD uptake by cells can be enhanced by
conjugating the QDs to cationic lipids or peptides39–42 or amphiphilic
proteins.43 Cationic lipid-capped QD
delivery into tumor cells was successfully demonstrated by Voura et al40 as was peptide-mediated delivery of QDs into Chinese
hamster ovarian cells.42 Cationic POSS
conjugated to BODIPY was seen to be taken up by cells with a uniform cytoplasmic
distribution.44 Although the M-POSS used
to coat our QDs is not the cationic form, it is likely that the amphiphillicity that it
imparts to the QD structure has a role in its increased intracellular uptake across the
lipophilic cell membranes. At 24 hours post incubation, a significant rise in fluorescence
of both POSS and MSA QDs could be detected due to increased intracellular uptake over time.
However, POSS-QDs fluoresced more brightly compared to MSA-QDs owing to their relatively
higher photostability on exposure to oxidative environments.Our study demonstrates the application of a novel POSS nanoparticle as coating for QDs for
biological application. We used CdTe cored QDs without a ZnS shell. It has been established
that a QD coating of a higher band gap material removes surface defects and retains
excitons, thus leading to prolonged photostability, higher quantum yield, and enhanced
biocompatibility.45–48 However, QD toxicity is not eliminated as
ZnS-coated QDs do show concentration dependent increase in toxicity.38 Aqueous solubility still requires further coating of the
ZnS shell with materials such as MSA, PEG, dihydrolipoic acid, silica, dendrimers,
amphiphilic polymers, phospholipids micelles, etc. for biological application.9,15,49,50 This significantly increases the size of the coated QDs
(15–100 nm), leading to problems of excretion and QD sequestration into the organs
of the RES, apart from significant limitation to their biological applications. We used
POSS, MSA and D-Cysteine to coat QDs in an attempt to achieve solubility with the MSA
ligand, and biocompatibility and stability through the POSS coating while retaining the
small QD size. Although the toxicity of POSS and MSA-QDs is comparable, POSS QDs show
marginally lower cell viability compared to MSA-QDs at 5 μg/mL. This is unlikely to
be caused by the surface coating itself as the biocompatibility of POSS has been well
established. Furthermore, the enhanced photostability of the POSS-QDs compared to MSA-QDs
indicates that the POSS coating adequately shields the core from the effects of
photochemical oxidation. Therefore, the most likely explanation for this effect is the
higher cellular uptake of POSS- QDs, which leads to reduced cell viability. This particular
property, in addition to enhanced photostability, may allow lower concentrations of POSS-QDs
to be used for various biological applications, such as long term in vitro and in vivo
imaging applications like single particle tracking and stem cell tracking as well as various
biosensing applications that rely on a small QD size.
Conclusion
We have demonstrated that the novel POSS coating confers photostability, colloidal
stability, and biocompatibility on MSA and D-cysteine stabilized CdTe core QDs. Although the
biocompatibility of POSS-QDs is comparable to MSA-QDs, the POSS coating imparts
amphiphillicity to the QD surface, allowing rapid intracellular uptake and brighter
fluorescence, which eventually leads to lower concentrations of QDs required for use.
POSS-QDs retain surface reactive groups for bioconjugation, which along with their small
size, confers numerous advantages for use in various biomedical applications. The POSS
molecule is known to confer anti-thrombogenic properties when incorporated in polymer
nanocomposites for vascular grafts.26 Few
studies have examined the hemocompatibility of QDs, which is essential prior to any
consideration for in vivo and clinical application. It is likely that the POSS coating may
impart similar properties to QDs, but further testing is required to establish this effect.
Future experiments to investigate in vivo biodistribution and toxicity of POSS-coated QDs
are now in progress to move them one step closer to clinical application.
Authors: Ruben Y Kannan; Henryk J Salacinski; Jaco De Groot; Ian Clatworthy; Laurent Bozec; Mike Horton; Peter E Butler; Alexander M Seifalian Journal: Biomacromolecules Date: 2006-01 Impact factor: 6.988
Authors: Eunkeu Oh; Rong Liu; Andre Nel; Kelly Boeneman Gemill; Muhammad Bilal; Yoram Cohen; Igor L Medintz Journal: Nat Nanotechnol Date: 2016-02-29 Impact factor: 39.213
Authors: Lara Yildirimer; Asma Buanz; Simon Gaisford; Edward L Malins; C Remzi Becer; Naiem Moiemen; Gary M Reynolds; Alexander M Seifalian Journal: Sci Rep Date: 2015-10-14 Impact factor: 4.379